five

Cannabis Extract Market Share Analysis 2024 - 2033

收藏
marketresearch.biz2024-01-09 更新2025-01-15 收录
下载链接:
https://marketresearch.biz/report/global-cannabis-extract-market/
下载链接
链接失效反馈
官方服务:
资源简介:
<h2>Cannabis Extract Market Size, Share, Trends Analysis</h2> The <strong>Cannabis Extract Market</strong> was valued at <strong>USD 10.19 billion</strong> in 2022. It is expected to reach <strong>USD 67.5 billion</strong> by 2032, with a <strong>CAGR of 21.4%</strong> during the forecast period from 2023 to 2032. <img class="aligncenter wp-image-42769" src="https://marketresearch.biz/wp-content/uploads/2024/01/cannabis-extract-market-by-type.jpg" alt="cannabis extract market by type" width="744" height="457"> The surge in demand in the pharmaceutical industry and the legalization of cannabis are some of the main driving factors for the cannabis extraction market growth. Medical cannabis, which is also known as medical marijuana (MMJ), is cannabis and cannabinoids that are advised by medical experts for patients to relieve pain from any kind of chronic disease. Due to government restrictions and manufacturing, cannabis as medicine has not been rigorously tested, limiting clinical research efforts to discovering its safety and usage for treating diseases. Cannabis offers many therapeutic effects, from relieving chemotherapy-induced nausea and vomiting, enhancing immunity in those living with HIV/AIDS, and relieving chronic pain or muscle contractions to decreasing chronic discomfort and muscle spasms. According to the European Commission, 2.77 million cancer cases will be anticipated in 2022 and death cases related to cancer will increase by 2.4% year on year compared with 2020. 31% of men and 25% of women will be diagnosed before reaching 75 years of age; whilst 14% of male cancer victims and 9% of female ones will ultimately succumb. WHO estimates that by 2023 approximately 50 million individuals will have epilepsy, one of the most prevalent neurological disorders worldwide. With proper treatment over 70% could live seizure-free lives - marijuana helps slow cancer cell growth while oral cannabis minimizes side effects associated with chemotherapy treatment. Epidiolex is a <a href="https://marketresearch.biz/report/cannabidiol-cbd-oil-market/">medical cannabidiol</a> (CBD) product designed to treat rare, severe, and specific forms of epilepsy. Many Americans are supporting the legalization of cannabis. According to the Pew Research Centre, 88% of American individuals support the legalization and 59% of individuals suggest that the legalization of cannabis should be only for medical and recreational usage. Of those, 30% of individuals advise that legalization should be strictly used for medical purposes. The demand for cannabis is not limited to medicinal use but it is also widely used in food and beverages as well as in the cosmetic industry. Cannabis is used while making chocolates to drink and other savory dishes, due to this chefs can boost the flavors, create exceptional aromas, and even customize the dining experience according to specific choices. The demand for cannabis extract is expected to increase rapidly because of the numerous benefits across different sectors, which will assist in expanding the market in the future.

<h2>大麻提取物市场规模、份额及趋势分析</h2>大麻提取物市场在2022年达到了<em>10.19亿美元</em>的估值。预计到2032年,该市场规模将达到<em>675亿美元</em>,在2023年至2032年的预测期内,年复合增长率(CAGR)将达到21.4%。<img class="aligncenter wp-image-42769" src="https://marketresearch.biz/wp-content/uploads/2024/01/cannabis-extract-market-by-type.jpg" alt="大麻提取物市场类型" width="744" height="457">药企需求的激增和大麻的合法化是推动大麻提取物市场增长的主要动力之一。医疗大麻(亦称医疗大麻)(MMJ)是指由医疗专家建议用于患者以缓解各种慢性疾病引起的疼痛的大麻及其大麻素。<br>由于政府管制和制造限制,大麻作为药物尚未经过严格的测试,这限制了临床研究在发现其安全性和治疗疾病用途方面的努力。<br>大麻具有多种治疗功效,从缓解化疗引起的恶心和呕吐,增强HIV/AIDS患者的免疫力,到缓解慢性疼痛或肌肉痉挛,以及减轻慢性不适和肌肉痉挛。<br>根据欧盟委员会的预测,2022年预计将有2770万例癌症病例,与2020年相比,癌症相关死亡病例年增长率将达到2.4%。31%的男性患者和25%的女性患者将在75岁之前被诊断出来;而14%的男性癌症患者和9%的女性癌症患者最终将死于癌症。<br>世界卫生组织(WHO)估计,到2023年,大约有5000万人将患有癫痫,这是全球最常见的神经系统疾病之一。通过适当的治疗,70%的患者可以过上无癫痫的生活——大麻有助于减缓癌细胞生长,而口服大麻可以减少化疗治疗相关的副作用。<br>Epidiolex是一种旨在治疗罕见、严重和特定形式癫痫的医疗用大麻二酚(CBD)产品。许多美国人支持大麻的合法化。根据皮尤研究中心的调查,88%的美国民众支持大麻的合法化,其中59%的人建议大麻的合法化应仅限于医疗和娱乐用途。其中,30%的人认为大麻的合法化应严格用于医疗目的。<br>大麻的需求不仅限于医疗用途,还广泛应用于食品饮料和化妆品行业。大麻被用于制作可饮用的巧克力和其他风味菜肴,这使得厨师可以提升风味,创造卓越的香气,甚至根据特定的选择定制用餐体验。预计随着大麻提取物在多个领域的广泛应用,其需求将迅速增长,这将有助于在未来扩大市场。
提供机构:
MarketResearch.biz
5,000+
优质数据集
54 个
任务类型
进入经典数据集
二维码
社区交流群

面向社区/商业的数据集话题

二维码
科研交流群

面向高校/科研机构的开源数据集话题

数据驱动未来

携手共赢发展

商业合作